Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Exemplar
98,8
%
| 12 | 44,7 % | 6 | 98,8 % | -48,81% |
Biopharmaceuticals
1,2
%
| 15 | 55,3 % | 0 | 1,2 % | -99,50% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 27 | 99,1 % | 6 | 100,0 % | -76,66% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Helen Sabzevari
CEO | Chief Executive Officer | 62 | 01/01/20 |
Harry Thomasian
DFI | Director of Finance/CFO | 62 | 01/10/21 |
Randal Kirk
CHM | Chairman | 70 | 01/02/08 |
Amy Lankford
CTO | Chief Tech/Sci/R&D Officer | - | - |
Rutul Shah
COO | Chief Operating Officer | - | - |
Investor Relations Contact | - | 01/01/18 | |
Jim Shaffer
PRN | Corporate Officer/Principal | - | - |
Rob Russell
HRO | Human Resources Officer | - | - |
Don Lehr
LAW | General Counsel | 49 | 01/01/09 |
Corporate Officer/Principal | 59 | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Randal Kirk
CHM | Chairman | 70 | 01/02/08 |
Dean Mitchell
BRD | Director/Board Member | 68 | 01/03/09 |
Jeffrey Perez
PRN | Corporate Officer/Principal | 52 | 01/08/14 |
Fred Hassan
BRD | Director/Board Member | 78 | 30/06/16 |
Jeffrey Kindler
BRD | Director/Board Member | 68 | 28/11/11 |
Cesar Alvarez
BRD | Director/Board Member | 76 | 01/02/08 |
James Turley
BRD | Director/Board Member | 68 | 16/04/14 |
Steven Frank
BRD | Director/Board Member | 64 | 01/02/08 |
Director/Board Member | 56 | 25/04/17 | |
Helen Sabzevari
CEO | Chief Executive Officer | 62 | 01/01/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 259 899 121 | 219 740 867 ( 84,55 %) | 7 479 431 ( 2,878 %) | 84,55 % |
Coordinate società
Settore
Vendite per attività
Vendite per regione
Variaz. 1 gen. | Capi. | |
---|---|---|
+33,04% | 704 Mrd | |
+28,59% | 577 Mrd | |
-3,57% | 348 Mrd | |
+18,45% | 327 Mrd | |
+4,64% | 288 Mrd | |
+14,81% | 234 Mrd | |
+4,93% | 198 Mrd | |
-9,78% | 194 Mrd | |
-4,28% | 147 Mrd |